Abstract

BackgroundAcute gout is usually associated with a decrease in serum uric acid (SUA) level but the mechanism responsible for this phenomenon remains unclear.ObjectivesWe aimed to investigate relationships between changes in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome
Po-Ren Hsueh ... Hung-Bin Tsai
American Journal of Kidney Diseases | VOL. 45
Po-Ren Hsueh, et. al.Po-Ren Hsueh ... Hung-Bin Tsai
01 Jan 2004
P5413Effect of empagliflozin as add-on therapy on serum uric acid level in patients with type 2 diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study
A Kikuchi ... T Morita
European Heart Journal | VOL. 40
A Kikuchi, et. al.A Kikuchi ... T Morita
01 Oct 2019
Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia
Jian Li ... Lijun Jin
Journal of Ethnopharmacology | VOL. 214
Jian Li, et. al.Jian Li ... Lijun Jin
09 Dec 2017
Effect of Atorvastatin Alone and in Combination with Aspirin on Uric Acid Handling of Normal Rats
Sadia Chiragh ... Muhammad Ubaidullah Khan
Proceedings | VOL. 35
Sadia Chiragh, et. al. Sadia Chiragh ... Muhammad Ubaidullah Khan
21 Apr 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers